The global feed additive nosiheptide premix market size is estimated to total USD 713.1 million in 2024 and USD 1,720 million by 2034. Sales are projected to rise at a CAGR of 9.2% over the forecast period between 2024 and 2034. The revenue generated by feed additive nosiheptide premix in 2023 was USD 650 million.
The feed additive nosiheptide premix market offers a dynamic landscape characterized by various factors. These include increasing demand for high-quality animal protein and rising concerns over animal health and welfare.
Surging consumer awareness regarding the significance of safe and nutritious food is also fueling the adoption of feed additive nosiheptide premixes among end users. Similarly, improving regulatory frameworks impacting the use of antibiotics in animal production will benefit the industry.
Global Feed Additive Nosiheptide Premix Market Assessment
| Attributes | Description |
|---|---|
| Historical Size, 2023 | USD 650 million |
| Estimated Size, 2024 | USD 713.1 million |
| Projected Size, 2034 | USD 1,720 million |
| Value-based CAGR (2024 to 2034) | 9.2% |
Increasing livestock production operations is another growth factor that is positively influencing the demand for nosiheptide premix solutions. The constant emphasis on enhancing feed efficiency and animal performance is anticipated to expand the industry size over the estimated period. Apart from this, the progressions in feed technology, animal husbandry practices, and genetic selection are raising the demand for nosiheptide premixes.
The manufacturers are continuously investing in research and development in production and feed formulation to innovate the nosiheptide premix industry. Partnerships, strategic collaborations, and investment in research and development are widening product portfolios and driving market growth significantly.
The industry is posed with the challenge of regulatory restriction on feed additive nosiheptide premix for use as antibiotics. Another key challenge is the fluctuation in raw material prices that constrains growth. Additionally, concerns over antimicrobial resistance are also hindering the use of feed additive nosiheptide premix.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Nosiheptide Premix Has a Key Role in the Gut Health Management Revolution
The surge of antibiotic resistance in poultry is leading to a revolution in gut health management. Producers, as well as consumers, are becoming concerned over the potential human health risks linked with antibiotic use in poultry farming. This has created prospects for alternatives like nosiheptide premix.
The product stands to benefit substantially from this shift as it provides a promising approach to boost bird performance and gut health without relying on antibiotics.
Nosiheptide premix has the potential to increase nutrient absorption, digestion, and overall bird health, resulting in better growth rates and lower disease susceptibility. This approach gets well with the expanding demand for responsible and sustainable poultry production.
Innovation in the Feed-Additive Nosiheptide Premix Industry
The industry is projected to be led by product development and innovation. In upcoming years, more firms are expected to be seen reformulating nosiheptide premix for improved functionalities. These include enhanced shelf life, easier application, and improved compatibility with existing feed additives. This could include innovations in premix packaging, encapsulation technologies, and particle size.
Over the forecast period 2024 to 2034, the market is projected to witness customized products for species-specific including chickens, geese, turkeys, and ducks. Key players offering advanced delivery methods and dosages to best address the distinct gut health requirements of every bird type. As many players focus on innovation and development the competition and effectiveness of evolving poultry health are enhanced.
Firms Adjust to Green Processes as Environmental Concerns Become Overbearing
With concerns increasing over the environment, manufacturers are focusing on sustainability and it is going to be key for the growth of the nosiheptide premix industry. Manufacturers are investing in sustainable and eco-friendly sources of raw materials for nosiheptide premix production in partnership with suppliers of raw materials.
Manufacturers are expected to explore eco-friendly processes during the production process. This could entail reducing waste generation, limiting energy consumption, and executing recycling initiatives. By following sustainable practices, manufacturers are appealing to eco-conscious consumers and producers while also contributing to a sustainable food system.
The global feed additive nosiheptide premix market recorded a CAGR of 10.9% during the historical period between 2019 and 2023. The expansion of the feed additive nosiheptide premix market was positive, as it reached a value of USD 650 million in 2023.
During the historical period, nosiheptide premix offered a unique mode of action. Research was initiated to provide strong evidence for its distinct functionality in boosting gut health and growth. The initiation of scientific discoveries fueled the demand for feed additive nosiheptide premixes.
Approvals for nosiheptide premix in main poultry-producing countries have opened doors for broader acceptance. Further, players were dealt with challenges in developing nosiheptide premix at a commercially viable scale before 2023. By overcoming this challenge and offering new developments, players are attracting a new consumer base.
In 2020, coronavirus hit the industry and caused the shutdown of running factories. The economic slowdown also caused demand for poultry and livestock in HORECA and the residential sector to peter out. In the subsequent years, when the deadly virus loosened its grip, the market settled and continued to grow in the forecast period.
The upward trajectory of feed additive nosiheptide premix is expected to shoot up at a 9.2% CAGR through 2034. By the end of 2034, the market is projected to reach USD 1,720 million. Promising results of this premix in ducks and chickens have led players to explore the safety and efficacy of these premixes in other poultry species like geese or turkeys. This is expected to offer growth avenues for new market segments.
Distinct long-term studies evaluate the effect of nosiheptide premix on the gut microbiome, poultry health, and potential resistance development over long periods. These are also instrumental in improving the sales of feed additive nosiheptide premix.
Principal Consultant
Top-tier companies that provide nosiheptide premix offerings are investing in research and development as they have enough funds to sustain such endeavors. The result of these efforts is the creation of improved or new product formulations to meet the evolving requirements of livestock producers.
In research activities, focus is being given to addressing specific challenges like antibiotic resistance, targeting new animal species, and creating more effective formulations.
On the back of steady revenue streams of tier 1 companies, they are entering new markets or enlarging their presence in existing ones. Players are thus maneuvering the marketspace with partnerships, acquisitions, or organic growth tactics.
Cost optimization is another method to keep companies’ growth in check. For cost-cutting, companies are seeking efficient manufacturing processes, streamlining operations, or negotiating better deals with suppliers.
Tier 2 companies include those who exercise power over regional markets. These players are targeting certain regional requirements or emphasize under-served segments.
A few examples of this strategy include specializing in certain types of livestock, offering customized premix options, or serving organic or antibiotic-free production systems. Further, players are closely monitoring and adhering to certain regulations associated with nosiheptide premixes in various regions
The following table has been formulated that provides a screenshot of growth patterns spotted over five key pockets. The United States leads the industry in terms of percentage. However, the country’s growth is estimated to be at the tail end due to a slightly slower uptake in the next ten years. In countries of Asia Pacific, like China, Japan, and South Korea, the sector is rising at 10%, 11%, and 12% CAGRs, respectively.
| Countries | CAGR 2024 to 2034 |
|---|---|
| United States | 9.5% |
| United Kingdom | 10.5% |
| China | 10% |
| Japan | 11% |
| South Korea | 12% |
The United States feed additive nosiheptide premix market is projected to maintain its dominance globally. The industry is estimated to touch USD 306.1 million by 2034. In the upcoming decade, the consumption rate is forecast to expand at 9.5% CAGR.
Nosiheptide premix is a sulfur-containing peptide antibiotic that is solely used for animal feed. The product is gaining widespread recognition on account of its environmental friendliness.
Several companies in the United States engineer feed solutions using high-quality feed ingredients for chickens. These solutions are developed, customized, sourced, and offered across the globe. Companies are also hiring feed additive specialists to offer value-added products.
The United Kingdom industry is maneuvering at a speed of 10.5% CAGR. It is poised to reach USD 69.5 million by 2034. New feed options in the industry and shifting preferences have changed the industry dynamics over the years. Throughout 2019 to 2023, the adoption of feed additive nosiheptide premix in the nation increased at 14.2% CAGR.
The poultry sector in the United Kingdom supports the economy. British farmers rear around 1 billion broilers for consumption on an annual basis. The sector contributes over USD 4.99 billion to the United Kingdom economy, creating growth prospects for the target industry.
The poultry meat sector extends employment to about 1,00,000 people, ranging from farm managers and farmers to processors, lorry drivers, and haulage companies. Besides, thousands of additional workers are hired for seasonal poultry production every Christmas. The flourishing poultry sector in the United Kingdom gives impetus to the feed additive nosiheptide demand.
The use of feed additive nosiheptide premix as a growth promoter for livestock is projected to sustain over the next decade. Players are strengthening their distribution channels to deepen their penetration across the nation. They are also employing varied tactics to attract a larger consumer base.
The feed additive nosiheptide premix market in China is forecast to register a CAGR of 10% from 2024 to 2034. By 2034, sales in the country are set to total USD 271.4 million.
Rising human population and inflating incomes of people residing in China are proportionally raising the demand for food and various other livelihood resources. The demand for nutritious and wholesome food is ever-expanding and the animal husbandry sector has contributed to the requirements of people.
Several measures have been applied to accelerate the productivity of livestock, including the use of feed additive nosiheptide premix. The use of this premix has been instrumental in raising the production of fish, eggs, milk, and meat.
Players offering feed additive nosiheptide premixes are developing high-quality animal protein. Additionally, they are tying up with other players to learn from each other’s expertise and thrive in the industry.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The top-performing sectors are mentioned below. The below 4% segment in the concentration category accounted for a share of 56% in 2023. Under the application category, the poultry segment led with a 65% value share in 2023.
| Segment | Below 4% (Concentration) |
|---|---|
| Value Share (2023) | 56% |
Based on concentration, the below 4% segment accounted for 56% of the share in the feed additive nosiheptide premix market. The demand for such solutions is rising as research suggests that a concentration below 4% is enough to offer desired benefits in poultry gut performance and health.
A higher degree of concentration has no relation to further improvement. It could, however, raise the production costs. Thus, below 4% nosiheptide premix remains highly popular among consumers.
| Segment | Poultry (Application) |
|---|---|
| Value Share (2023) | 65% |
The use of feed additive nosiheptide premix for rearing poultry is expected to generate significant remuneration. According to the analysis, poultry segment’s share in the industry was 65% in 2023. Over the forecast period, this segment is anticipated to rise at an 8.8% CAGR.
Studies have been conducted that validate that nosiheptide premix boosts growth and leads to better feed conversion in ducks and chickens. The product can increase the yields and potentially lower the production costs for poultry farmers.
The use of nosiheptide premixes also prevents and manages diarrhea, which is a common problem in poultry that impacts development and survival rates. By enhancing gut health, the development of birds will also be healthier.
Increasing concerns about antibiotic resistance have been instrumental in exploring nosiheptide premix as a possible alternative to promote development and gut health in poultry. It is claimed to offer a different mode of action than antibiotics, thus reducing the chances of resistance development.
The feed additive nosiheptide premix market is competitive, with players strategically partnering to increase their share. Players are uniting with renowned poultry health and animal feed companies that could strengthen distribution networks and increase market access.
Companies in the feed additive nosiheptide premix landscape are also seeking regulatory approvals and penetrating new countries with substantial poultry production for the expanded customer base. Besides, the emerging methods for sustainably sourcing the raw materials that are deployed in the nosiheptide premix production is improving its appeal to discerning producers and consumers. In line with this, players are implementing eco-friendly practices through nosiheptide premix manufacturing to improve their image in the marketplace.
Profiling of Key Companies
ZHEJIANG ESIGMA BIOTECHNOLOGY CO., LTD.
The company was registered in 2016 in Hangzhou. It is a leading manufacturer, exporter, and distributor of poultry feed supplements in China. In emerging and neighboring countries like India, the company is verified by Trade India and considered a trusted seller of enlisted products. With wide experience in supplying and trading nosiheptide, the company has made a name for itself in various domains. The company has a customer-centric approach. It has a significant presence across the globe and serves a substantial consumer base. The quality-assured poultry feed supplements by ZHEJIANG ESIGMA BIOTECHNOLOGY CO., LTD. are easily available.
FENGCHEN GROUP CO., LTD.
FENGCHEN GROUP CO., LTD. is a Chinese pharmaceutical product supplier. The company sells poultry or livestock at competitive prices to boost feed efficiency remarkably. The feed additive nosiheptide premix is used to increase the weight of the poultry and livestock. The company is further focusing on upgrading the production line to raise its competitiveness in the industry.
In terms of concentration, the industry is bifurcated into below 4% and between 4% to 12%.
Based on application, the industry is classified into livestock and poultry.
Key countries of regions like North America, Latin America, Europe, East Asia, South Asia, Middle East and Africa (MEA), and Oceania have been examined in the report.
The global industry is projected to witness a CAGR of 9.2% through 2034.
The target industry stood at USD 650 million in 2023.
Global revenue is anticipated to reach USD 1,720 million by 2034.
South Korea is set to record a robust CAGR of 12% in the assessment period.
ZHEJIANG ESIGMA BIOTECHNOLOGY CO., LTD. and FENGCHEN GROUP CO., LTD.
1. Executive Summary 2. Industry Introduction, including Taxonomy and Market Definition 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments 4. Global Market Demand Analysis 2019 to 2023 and Forecast 2024 to 2034, including Historical Analysis and Future Projections 5. Pricing Analysis 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034 6.1. Concentration 6.2. Application 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Concentration 7.1. Below 4% 7.2. Between 4% to 12% 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Application 8.1. Livestock 8.2. Poultry 9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region 9.1. North America 9.2. Latin America 9.3. Western Europe 9.4. South Asia 9.5. East Asia 9.6. Eastern Europe 9.7. Middle East & Africa 10. North America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 11. Latin America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 12. Western Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 13. South Asia Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 14. East Asia Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 15. Eastern Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 16. Middle East & Africa Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 17. Sales Forecast 2024 to 2034 by Concentration and Application for 30 Countries 18. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard 19. Company Profile 19.1. Mitsubishi Company 19.2. Zhejiang Esigma Animal Health 19.3. Anhui Wanbei Pharmaceutical 19.4. ZheJiang MingZhu Animal Health Products 19.5. Chattha Group 19.6. Zhejiang University Sunny Nutrition Technology 19.7. Shandong Shengli Bioengineering 19.8. Fenghe Bio-Technology 19.9. Bornsun Bioengineering
Explore Food and Beverage Insights
View Reports
Feed Additive Nosiheptide Premix Market
